A new approach for stable lentiviral vector producer cell line development

被引:0
|
作者
Tomas, H. A. [1 ,2 ]
Rodrigues, A. F. [1 ,2 ]
Formas-Oliveira, A. S. [1 ,2 ]
Alves, P. M. [1 ,2 ]
Carrondo, M. J. T. [1 ,3 ]
Coroadinha, A. S. [1 ,2 ]
机构
[1] IBET, Oeiras, Portugal
[2] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-1200 Lisbon, Portugal
[3] Univ Nova Lisboa, Fac Ciencias & Tecnol, P-1200 Lisbon, Portugal
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
P247
引用
收藏
页码:A100 / A100
页数:1
相关论文
共 50 条
  • [21] Generation of Stable Producer Cell Lines (PCL) of Lentiviral Vector (LV) Using PiggyBac Transposase
    Cui, Ruda
    Zeng, Yimeng
    Bhat, Vijetha
    Gu, Bingnan
    Seth, Anandita
    Shin, Young
    MOLECULAR THERAPY, 2020, 28 (04) : 432 - 432
  • [22] Lentiviral Vector Producer Cell Line Generation for Chimeric Antigen Receptor (CAR) T Cell Therapies
    Boura, Joana S.
    Todoric, Radmila
    Wright, Jordan
    Maunder, Helen
    Pearson, Laura J. E.
    Burton, Emma
    Ferluga, Sara
    Farley, Daniel C.
    Mitrophanous, Kyriacos A.
    Clarkson, Nicholas G.
    Stewart, Hannah J.
    MOLECULAR THERAPY, 2022, 30 (04) : 541 - 541
  • [23] Development and characterisation of cGMP-compliant stable packaging cell line for inducible lentiviral vector production
    Tomas, H.
    Krakowiak, J.
    Efstathiou, A.
    Page, E.
    Parker-Manuel, R.
    Dunajova, L.
    Zhang, L.
    Liu, Q.
    Cawood, R.
    Payne, T.
    HUMAN GENE THERAPY, 2019, 30 (08) : A26 - A26
  • [24] Novel Constitutive Producer Cell Line & GMP Compatible Dowstream Process for Lentiviral Vector Manufacturing
    Tomas, Helio A.
    Oliveiras, Ana S.
    Rodrigues, Ana F.
    Faria, Tiago
    Carrondo, Manuel J. T.
    Alves, Paula M.
    Peixoto, Cristina
    Coroadinha, Ana S.
    MOLECULAR THERAPY, 2018, 26 (05) : 152 - 152
  • [25] Development of inducible EIAV-based lentiviral vector packaging and producer cell lines
    Stewart, H. J.
    Leroux-Carlucci, M. A.
    Sion, C. J. M.
    Mitrophanous, K. A.
    Radcliffe, P. A.
    GENE THERAPY, 2009, 16 (06) : 805 - 814
  • [26] Development of inducible EIAV-based lentiviral vector packaging and producer cell lines
    H J Stewart
    M A Leroux-Carlucci
    C J M Sion
    K A Mitrophanous
    P A Radcliffe
    Gene Therapy, 2009, 16 : 805 - 814
  • [27] Generation of cGMP-compliant stable packaging and producer cell lines for inducible lentiviral vector production
    Dunajova, L.
    Krakowiak, J.
    Zgrundo, Z.
    Parker-Manuel, R.
    Su, W.
    Seymour, L.
    Cawood, R.
    Liu, Q.
    Payne, T.
    HUMAN GENE THERAPY, 2018, 29 (12) : A161 - A161
  • [28] Generation of cGMP-Compliant Stable Packaging and Producer Cell Lines for Inducible Lentiviral Vector Production
    Liu, Qian
    MOLECULAR THERAPY, 2019, 27 (04) : 161 - 161
  • [29] Scalable Lentiviral Vector Production Using Stable HEK293SF Producer Cell Lines
    Manceur, Aziza P.
    Kim, Howard
    Misic, Vanja
    Andreev, Nadejda
    Dorion-Thibaudeau, July
    Lanthier, Stephane
    Bernier, Alice
    Tremblay, Sonia
    Gelinas, Anne-Marie
    Broussau, Sophie
    Gilbert, Renald
    Ansorge, Sven
    HUMAN GENE THERAPY METHODS, 2017, 28 (06) : 330 - 339
  • [30] Continuous manufacturing of lentiviral vectors using a stable producer cell line in a fixed-bed bioreactor
    Stibbs, Dale J.
    Couto, Pedro Silva
    Takeuchi, Yasuhiro
    Rafiq, Qasim A.
    Jackson, Nigel B.
    Rayat, Andrea C. M. E.
    MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT, 2024, 32 (01) : 1 - 11